IL‐2 receptor antagonist induction vs no antibody induction
Bronchiolitis obliterans syndrome · lung transplant recipients
IL‐2 receptor antagonist induction showed no clear difference in bronchiolitis obliterans syndrome compared with no antibody induction (moderate certainty).
1 finding from 1 review
- RR 0.33 [0.07, 1.49]1 study · 25 participantsModerate